Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
12.92
+0.12 (0.94%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Avadel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Debt / Equity Ratio
0.540.40-6.201.850.80-4.46
Upgrade
Debt / FCF Ratio
-0.33-0.28-1.84-1.87-2.67-3.39
Upgrade
Asset Turnover
0.530.19--0.100.35
Upgrade
Inventory Turnover
0.69----2.91
Upgrade
Quick Ratio
2.373.221.778.9917.302.12
Upgrade
Current Ratio
2.823.641.819.1717.442.29
Upgrade
Return on Equity (ROE)
-99.52%-481.35%-481.49%-64.30%10.56%-
Upgrade
Return on Assets (ROA)
-34.44%-57.92%-31.32%-19.14%-9.90%-6.15%
Upgrade
Return on Capital (ROIC)
-45.19%-73.95%-35.73%-20.73%-11.64%-9.58%
Upgrade
Buyback Yield / Dilution
-39.29%-33.41%-2.66%-6.54%-46.89%-0.21%
Upgrade
Total Shareholder Return
-39.29%-33.41%-2.66%-6.54%-46.89%-0.21%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.